Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study

Last updated on 31-3-2022 by Nayema Van den Houte

Public Access


Sci. report, recommendat°, guidance doc., directive, monograph



Key findings In the beginning of July 2021 78.1% of the community dwelling population aged 18 years and above had developed anti-SARS-CoV-2 antibodies. This percentage was 98.9% among fully vaccinated people (since at least 2 weeks before being tested) and 28.9% among not vaccinated people. A higher prevalence of anti-SARS-CoV-2 antibodies is found in woman than in men. This is in line with literature findings indicating that women showed a higher immune response to COVID-19 vaccination. People with a higher education are more likely to have anti-SARS-CoV-2 antibodie…

Associated health topics:

QR code

QR code for this page URL